Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features

Divergent Oncogenic Changes Influence Survival Differences between Colon and Rectal Adenocarcinomas

(2011) Matthew F. Kalady et al.   DISEASES OF THE COLON & RECTUM

Novel Application of Structural Equation Modeling to Correlation Structure Analysis of CpG Island Methylation in Colorectal Cancer

(2010) Noriko Tanaka et al.   AMERICAN JOURNAL OF PATHOLOGY

Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas

(2010) Jin C. Kim et al.   ANNALS OF SURGICAL ONCOLOGY

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

(2010) Eddy HJ van Roon et al.   BMC CANCER

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features

(2010) Pei Woon Ang et al.   BMC CANCER

Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes

(2010) Atsushi Kaneda et al.   CANCER SCIENCE

The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status

(2010) A. M. Dahlin et al.   CLINICAL CANCER RESEARCH

Microsatellite Instability in Colorectal Cancer

(2010) C. Richard Boland et al.   GASTROENTEROLOGY

5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer

(2010) Rodrigo Jover et al.   GASTROENTEROLOGY

Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer

(2010) Inti Zlobec et al.   INTERNATIONAL JOURNAL OF CANCER

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

(2010) Katsuhiko Nosho et al.   JOURNAL OF PATHOLOGY

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

(2010) Sun Lee et al.   PATHOLOGY INTERNATIONAL

CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle

(2009) Mustafa A Arain et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Stage III Colorectal Cancer: Molecular Disparity Between Primary Cancers and Lymph Node Metastases

(2009) Craig A. Messick et al.   ANNALS OF SURGICAL ONCOLOGY

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer

(2009) A Lugli et al.   BRITISH JOURNAL OF CANCER

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

(2009) J. A. Sanchez et al.   BRITISH JOURNAL OF SURGERY

p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis

(2009) S. Ogino et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The intestine-specific transcription factor Cdx2 inhibits β-catenin/TCF transcriptional activity by disrupting the β-catenin–TCF protein complex

(2009) Rong-Jun Guo et al.   CARCINOGENESIS

Three DNA Methylation Epigenotypes in Human Colorectal Cancer

(2009) K. Yagi et al.   CLINICAL CANCER RESEARCH

Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer

(2009) Y. Baba et al.   CLINICAL CANCER RESEARCH

Genetic and molecular diversity of colon cancer hepatic metastases

(2009) Craig A. Messick et al.   SURGERY

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

(2009) Jung Ho Kim et al.   VIRCHOWS ARCHIV

Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor

(2008) Alexey E Granovsky et al.   CELL RESEARCH

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

(2008) S. Ogino et al.   GUT

Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?

(2008) Barry Iacopetta et al.   International Journal of Clinical Oncology

The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile

(2008) M Ferracin et al.   JOURNAL OF PATHOLOGY

Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status

(2008) Alessandro Lugli et al.   MODERN PATHOLOGY